baber/WOPTO huggingface dataset:
Patent FI-950356-A0 (FI)
Inventor: CLARKE ADRIENNE ELIZABETH
IPC: C09K8/20
Filed: 1995-01-27
Abstract: Methods of using cultured plant cell gums in the paper, adhesive, oil and gas, ink, lithography, textile, paint, ceramics, cleaning detergents, cosmetics, photography, explosive, firefighting, agricultural, and other industries are described. Industrial and cosmetic compositions containing cultured plant cell gums are also described.
Patent FI-953800-A0 (FI)
Inventor: HULBERT ANTHONY PETER
IPC: H04B7/005
Filed: 1995-08-10
Abstract: Rapid feedback control of transmit power for very low bit rate links is difficult because very little signal energy is available for measurement of power. However, the purpose of power control is to maintain a link error rate. By feeding back decisions from the receiving station to the transmitting station, the latter can detect errors at the receiving station. When an error is detected the transmit power is increased. When no error is detected the transmit power is reduced by a smaller amount. This maintains a constant bit error rate related to the ratio of the up and down step sizes. <MATH>
Patent FI-961014-A0 (FI)
Inventor: SPIROS SPIRO ROSS
IPC: B23K5/00
Filed: 1996-03-05
Abstract: A cell arrangement for the electrolysis of water to liberate hydrogen and oxygen gases is described. A cell unit (125) has a stacked arrangement of segmentation disks (114), a first type of (anode) cell plates (90), a second type of (cathode) cell plates (98) and separation membranes (116). Interconnecting conductive shafts (126-131) pass through holes (100,102) of the cell plates (90,98) to have selective electrical interconnection therewith. Water and electrolyte is supplied by inlet ports (108,110) to immerse the cell plates (90,98). The membranes (116) normally isolate adjacent cathode and anode plates (90,98) from the mixing of liberated oxygen and hydrogen gases whilst allowing ionic current flow. By selective adjustment of the water/electrolyte pressure differential on respective sides of the separation membranes (116), admixture of the liberated gases can be produced. The liberated gases discharge by outlet ports (104,106).
Patent FI-962020-A0 (FI)
Inventor: DOMAGALA JOHN MICHAEL
IPC: A61K31/365
Filed: 1996-05-13
Abstract: The present invention relates to novel tri- and tetrasubstituted pyrones and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The pyrone derivatives are useful in the development of therapies for the treatment of bacterial and viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of multifunctionalized pyrones and of related structures.
Patent FI-964099-A0 (FI)
Inventor: PARK CHUNG P
IPC: C08L23/06
Filed: 1996-10-11
Abstract: A polymer blend composition comprising: (a) from 0.5 to 99 percent by weight, based on the total weight of (a), (b), and (c), of an aliphatic  alpha -olefin homopolymer or interpolymer, or an interpolymer of an  alpha -olefin and a non-aromatic monomer interpolymerizable therewith; (b) from 0.5 to 99 percent by weight, based on the total weight of (a), (b), and (c), of a homopolymer or interpolymer of monovinylidene aromatic monomers, or an interpolymer of monovinylidene aromatic monomer and a monomer interpolymerizable therewith other than an aliphatic  alpha -olefin; and (c) from 0.5 to 99 percent by weight, based on the total weight of (a), (b), and (c), of a substantially random interpolymer comprising an  alpha -olefin and a vinylidene aromatic monomer. An expandable composition, comprising such polymer blend composition and an expanding agent; a foamed composition obtained by subjecting such an expandable composition to a foaming process; an article of manufacture molded from such a polymer blend composition; and a method of packaging using such a polymer blend composition.
Patent FI-965076-A0 (FI)
Inventor: WOODINGS CALVIN ROGER
IPC: D04H1/495
Filed: 1996-12-17
Abstract: PCT No. PCT/GB95/01441 Sec. 371 Date Dec. 20, 1996 Sec. 102(e) Date Dec. 20, 1996 PCT Filed Jun. 19, 1995 PCT Pub. No. WO95/35043 PCT Pub. Date Dec. 28, 1995Cigarette filters are disclosed which comprise entangled continuous filaments of lyocell. The filaments may be entangled for example by hydroentangling a web which comprises one or more layers of lyocell filaments in spread tow form or by directing radial or circumferential water jets at a tow of lyocell filaments in rod form.
Patent FI-970939-A0 (FI)
Inventor: LOERCKS JUERGEN
IPC: B32B9/02
Filed: 1997-03-05
Abstract: PCT No. PCT/EP95/03486 Sec. 371 Date Mar. 6, 1997 Sec. 102(e) Date Mar. 6, 1997 PCT Filed Sep. 5, 1995 PCT Pub. No. WO96/07693 PCT Pub. Date Mar. 14, 1996The invention relates to a molded part made of completely biodegradable starch foamed material to be used for protecting transported articles and to a method for its preparation, wherein the starch foamed material is expanded to form starch foam profiled sections which are self-adhesive when moisture is applied and can be processed individually or so as to form single or multi-layer foam panels. The advantages reside in improved operating properties and minimized expenditure on packaging.
Patent FI-971178-A0 (FI)
Inventor: OLKKONEN MIKKO
IPC: H04W88/14
Filed: 1997-03-20
Abstract: The invention relates to telecommunication networks and particularly to mobile networks using Asynchronous Transfer Mode (ATM) transmission systems. The invention also relates to the control of mobility and call control functions in ATM systems. According to the invention, a network element (MSC/BSC) of a telecommunication network, such as a mobile network, which in a conventional telecommunication network architecture ensures the switching of circuit-switched connections, is provided with an ATM switching function. ATM switching functions are controlled with the same call and switching control operations (31) that are conventionally used e.g. for the control of a TDM switching field (32) in a PLMN network element. In a minimum implementation, an ATM switching field (301) provided with a suitable control interface (30) is simply arranged in place of or parallel with the TDM switching field. The switching network element thus becomes an ATM network node of a physical or a logical interface layer. PLMN level signalling, mobility management and call control are implemented using solutions offered by existing mobile networks and current PLMN network elements.
Patent FI-973433-A0 (FI)
Inventor: ZGORZELSKI WOLFGANG
IPC: C07C29/88
Filed: 1997-08-21
Abstract: PCT No. PCT/EP96/00633 Sec. 371 Date Aug. 22, 1997 Sec. 102(e) Date Aug. 22, 1997 PCT Filed Feb. 14, 1996 PCT Pub. No. WO96/26173 PCT Pub. Date Aug. 29, 1996The invention relates to a process for the purification of C3-C10-alcohols by distillation, by distilling the alcohols at 150 to 200 DEG  C. in the presence of 10 to 1000 ppm of alkali metal hydroxide.
Patent IL-65010-A0 (IL)
Title: Novel 4-aroylimidazol-2-ones
IPC: C07D405/06
Filed: 1982-02-14
Abstract: Novel 4-aroylimidazol-2-ones of the following general structure which are useful as antihypertensives, cardiotonics and antithrombotics <CHEM> wherein Ar is 2-furyl, 2-thienyl or phenyl, the latter of which may optionally be substituted with one or two X groups; X is halogen, hydroxy, C1-4 alkyl, C1-4 alkoxy, methylenedioxy, C1-4 alkylthio, C1-4 alkylsulfoxide, C1-4 alkylsufone, CF3, -SO2N(R2)2, NR3R4, pyrrolidino, piperidino, morpholino, piperazino or N min -alkyl-piperazino, R is hydrogen, C1-4 alkyl, C1-4 alkylcarbonyl or benzyl; each of R1, R2, R3 and R4 are hydrogen or C1-4 alkyl; and the pharmaceutically acceptable salts thereof.
Patent IL-74530-A0 (IL)
Title: Structure with membranes having continuous pores,its production and its use
IPC: B01J47/00
Filed: 1985-03-07
Abstract: PCT No. PCT/EP85/00089 Sec. 371 Date Oct. 28, 1985 Sec. 102(e) Date Oct. 28, 1985 PCT Filed Mar. 8, 1985 PCT Pub. No. WO85/04111 PCT Pub. Date Sep. 26, 1985.A structure usable as an ultrafiltration membrane has membranes (20) with continuous pores which are linked to or into an appropriately porous carrier (21). Each of these membranes (20) consist of protein molecules or protein containing molecules arranged according to a two-dimensional crystal lattice, between which continuous pores of equal size and form remain free, and they are advantageously formed from molecules, which were particularly separated from cell-membranes of procaryons, by means of a recrystallization process designated as self-organization, and which are preferably deposited on or into the carrier (21) and are cross-linked with the carrier (21) intra- or intermolecularly, respectively, through foreign molecules. The structure is suitable, furthermore, for use as a separating organ for a gas separation or for an ion exchange process, as well as for use as a carrier structure for other semi-permeable membranes, such as hyperfiltration membranes. Moreover, with membranes in vesicle form it can serve as a chromatography column and, in the form of film, as envelope material for the most varied substances.
Patent IL-83377-A0 (IL)
Title: Nmr imaging with paramagnetic polyvalent metal salts of poly(acid-alkylene-amino)-alkanes
IPC: C07C67/00
Filed: 1987-07-30
Abstract: The invention provides the use of a physiologically compatible chelate complex of a chelating compound and a paramagnetic ion of a lanthanide element having an atomic number in the range 57 to 70 or of a transition metal having an atomic number selected from 21 to 29, 42 and 44 and of a non-paramagnetic organic calcium salt for the preparation of a magnetic resonance imaging contrast medium by admixture of said complex and said organic salt. The admixed calcium serves to enhance the biotolerability of the paramagnetic chelate containing MRI contrast medium.
Patent IL-94660-A0 (IL)
Title: 4-(4-(4-(4-((2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)triazolones and imidazolones,their preparation and antifungal compositions containing them
IPC: A61K31/41
Filed: 1990-06-07
Abstract: 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4 -yl]methoxy]pheny l ]-1-piperazinyl]phenyl]triazolones and imidazolones of formula <CHEM>  wherein  Q is CH or N;  Y is a radical of formula <CHEM> R<1> is C5-7cycloalkyl or mono-, di-, tri-, tetra- or pentahaloC1-4alkyl; and R<2> is C1-6alkyl, C5-7cycloalkyl or mono-, di-, tri-, tetra- or pentahaloC1-4alkyl, the acid addition salts and stereoisomeric forms thereof; said compounds having antifungal properties. Pharmaceutical compositions containing such compounds as an active ingredient; methods of preparing said compounds and pharmaceutical compositions.
Patent IL-96619-A0 (IL)
Title: Imidazole derivatives,process for their preparation and pharmaceutical compositions containing them
IPC: A61K31/505
Filed: 1990-12-10
Abstract: Imidazole derivatives of formula (I) wherein A represents methylene or a group -CH2-A'-CH2- wherein A' represents a direct bond, linear alkanediyl, alkenediyl or alkynediyl, hydroxymethylene, or optionally substituted phenylene; R<1> and R<2> each represents hydrogen, halogen, alkyl, alkoxy, alkylthio, alkylamino, carboxy or alkoxycarbonyl; a and b are 0, 1 or 2; and Het represents a heterocyclic group containing from 5 to 7 ring atoms chosen from carbon, nitrogen, sulphur and oxygen atoms, and salts thereof are inhibitors of acyl coenzyme-A: cholesterol-O-acyl transferase useful for the treatment of conditions such as atherosclerosis, hyperlipidaemia, cholesterol ester storage disease and atheroma in vein grafts.
Patent IL-99047-A0 (IL)
Title: Peptides with a characteristic antigenic determinant for alpha 1-microglobulin
IPC: C12P21/08
Filed: 1991-08-01
Abstract: A peptide according to the invention is a maximum of 40 amino acids long and contains a sequence which is at least 6 amino acids long from the amino-acid part-sequence between amino acids 144 and 183 of human  alpha 1-microglobulin and/or a sequence which is at least 6 amino acids long from the amino-acid part-sequence between amino acids 1 and 20 of human  alpha 1-microglobulin. An antibody according to the invention is able to bind specifically both to one of the peptides according to the invention and to human alpha 1-microglobulin. To determine human  alpha 1-microglobulin in a sample liquid by an immunoassay, the sample liquid is contacted simultaneously or sequentially with defined amounts of the antibody and peptide components, one of the components being labelled and the determination taking place via this label. <IMAGE>
Patent AU-PN538495-A0 (AU)
Title: Disposable oxygenating device
IPC: A61M16/12
Filed: 1995-09-12
Abstract: PCT No. PCT/AU96/00417 Sec. 371 Date Sep. 25, 1998 Sec. 102(e) Date Sep. 25, 1998 PCT Filed Jul. 2, 1996 PCT Pub. No. WO97/10018 PCT Pub. Date May 20, 1997A disposable oxygenating device comprising a body and a collapsible bag coupled thereto, the body including first coupling means being couplable to a source of oxygen, second coupling means being couplable to an endotracheal tube, laryngeal mask or the like, a connector to which the bag is connected, an oxygen duct in fluid communication with the first coupling means having an outlet orifice which in use delivers oxygen from the source of oxygen to inflate the bag with oxygen, and an outlet, the arrangement being such that, in use, during an inspiration cycle, oxygen from the gab passes through the second coupling means and, during an expiration cycle, expiration products pass through the body and are expelled through the outlet.
Patent FI-20031315-A0 (FI)
Inventor: AUNOLA MIKA
IPC: A63C11/08
Filed: 2003-09-15
Abstract: The invention relates to a treatment apparatus of the sliding surface of sports gear comprising at least one treatment web ( 1 ), which is arranged to pass from a web roll ( 2 ) into a removal space ( 5 ) via a first guide surface ( 3 ) and a second guide surface ( 4 ), and a heating element ( 6 ) disposed between the first and second guide surface at a distance from the treatment web. According to the invention, the treatment apparatus includes at least one means ( 7, 8, 17 ) for contacting the treatment web ( 1 ) with the heating element ( 6 ) by moving the guide surfaces ( 3, 4 ) with respect to the heating element ( 6 ) and/or by moving the heating element ( 6 ) with respect to the treatment, web ( 1 ), and the heating element ( 6 ) includes elasticity ( 13 ) so that the heating element follows the sliding surface being treated uniformly and substantially with a standard pressure.
Patent FI-20045349-A0 (FI)
Inventor: JOKELA HARRI
IPC: H04W4/029
Filed: 2004-09-20
Abstract: A mobile system comprising a communication group for IP-based group speech communication as well as an access network and a packet data network connected to it, for transmitting IP data packets between terminals of the communication group and a group speech communication server. The mobile system comprises a server unit functionally connected to at least one server controlling group speech communication, the server unit being arranged to store for the speech communication group to be established location-related specifications comprising a predetermined maximum distance from a reference point, set between the group members; and to control the establishment of an IP-based speech communication group between at least two of the terminals in such a way that the activation of the group members requires location within the activity are determined by the maximum distance.
Patent FI-20075971-A0 (FI)
Inventor: TALLBERG THOMAS
IPC: A61K35/30
Filed: 2007-12-28
Abstract: Biological medical means for treating sterile inflammatory diseases are disclosed. The invention relates to the use of L-arginine-hydrochloride (Arg) or lysine (Lys) and L-leucine (Leu) for the manufacture of a pharmaceutical composition for treating or preventing sterile inflammation. The composition further comprises trace elements chromium (Cr), tin (Sn), selenium (Se), strontium (Sr), vanadium (V), wolfram (W) and folic acid. The pharmaceutical composition can further comprise zinc (Zn) and or manganese (Mn) as well as central nervous system (CNS) lipids. Sterile inflammations are related to disorder such as fibromyalgia, Crohn's disease, psoriasis and rheuma.
Patent IL-100347-A0 (IL)
Title: High strength nonwoven fabric and its production
IPC: B32B5/02
Filed: 1991-12-12
Abstract: High loft durable nonwoven material comprising facing and base components and corresponding process for preparation by     (a) forming and compiling a facing component (1A); (b) lightly bonding the compiled facing webs, utilizing a low density bonding pattern (20A);   (c) laying a web (23A); and (d) bonding (20AB) said laid web to form a base component to said facing component, utilizing a substantially greater bonding density then employed for said facing component.   <IMAGE>
Patent IL-115217-A0 (IL)
Title: Process for hydrating soft contact lenses
IPC: G02C11/00
Filed: 1995-09-08
Abstract: A process for releasing leachable substances from a polymeric contact lens blank. The contact lens is confined in a cavity within a carrier to permit the hydration of the lens without permitting it to invert or roll over. A fluid flow is introduced into the cavity about the lens to extract leachable material from the lens. The process significantly reduces the amount of leaching fluid that is used and the amount of time that is needed for hydration, washing and extraction.
Patent IL-133394-A0 (IL)
Title: A process for the preparation of macrocyclic chelants and the chelates thereof with paramagnetic metal ions
IPC: C07D257/02
Filed: 1998-06-03
Abstract: A process for the preparation of complexes of macrocyclic chelants with paramagnetic metal trivalent ions of formula (XII) wherein R1, R2 and Me3+ are as described in the following, comprising: a) reaction of 1,4,7,10-tetraazacyclododecane with triethyl orthoformate to give 5H,9bH-2a,4a,7,9a-octahydrotetraazacycloocta[cd]pentalene; b) carboxymethylation reaction in water; c) hydrolysis reaction in basic conditions; d) alkylation according to known methods with an epoxide in water; e) complexation according to known methods carried out in water by addition of a paramagnetic metal salt; f) purification by diafiltration, final desalting of the aqueous solution on ion exchange resins and g) crystallization or recovery.
Patent IL-133399-A0 (IL)
Title: Plug module with active-passive switching
IPC: H01R13/639
Filed: 1999-12-09
Abstract: A module carrier with a plug module (2) can be moved into and out of a rear final position (10) with an insertion and removal grip (5). A spring-actuated lock (12) at the front side (7), which secures the insertion and removal grip in the rear final position, actuates a switching element (11) for an active switching of the plug module after an effective locking position has been reached. A pressing down of the lock (12) effects a passive switching in the locked state before the insertion and removal grip (5) is unlocked after a further displacement distance of the lock and mechanically stores the unlocking in cooperation with lock (12).
Patent IL-136623-A0 (IL)
Title: Flavouring materials from yeast extracts
IPC: A23L27/00
Filed: 1998-12-11
Abstract: Flavouring materials may be produced from filamentous fungi by contacting them with water at a temperature sufficient to reduce their nucleic acid content and concentrating or separating solids from the resulting aqueous solution. The materials are then further subjected to a chemical reaction for example with a sulphur containing amino acid.
Patent IL-137662-A0 (IL)
Title: Osteoimplant and method for its manufacture
IPC: A61L27/36
Filed: 1999-02-05
Abstract: An osteoimplant comprises a solid aggregate of bone derived elements, adjacent bone-derived elements being bonded to each other through chemical linkages between their adjacent surface-exposed collagen. Various other components can be incorporated into the bone implant material such as bone-growth inducing substances.
Patent IL-141010-A0 (IL)
Title: Method for producing atropic acid ethyl ester
IPC: C07C67/343
Filed: 1999-07-28
Abstract: A process for preparing ethyl atropate by reacting ethyl phenylacetate with paraformaldehyde in the presence of a base is described and entails employing as ethyl phenylacetate a product which contains not more than 0.03% of the corresponding methyl phenylacetate, and carrying out the reaction in N-methyl-pyrrolidone or N,N-dimethylformamide.
Patent IL-158974-A0 (IL)
Title: Seat fixing
IPC: B60N2/24
Filed: 2002-05-22
Abstract: The invention relates to a seat fixing, in particular for rail vehicles for personal transport. The aim of the invention is to disclose a seat fixing which may be flexibly applied, independent of the usual height and positional variation of the C-rails, whereby said flexibility permits the number of differing seat holders to be reduced, thus leading to a lower price. Three or more different seat heights (between the range DeltaH≅120 mm) should also be capable of being set and should be simple to assemble and various seat shell thicknesses or different types of cushion systems from different manufacturers should also be capable of being positioned in the functionally required seat height. The above is achieved with a seat fixing comprising a horizontal support, fixed on one side to vertical elements and at least one cross-piece, fixed on one side to the horizontal support and on the other side to the vertical elements and/or to the floor in the vicinity of a corner region between the vertical elements and a floor. The horizontal support is fixed to an upper connection point on the vertical elements by means of a side wall adaptation element, in which the side wall adaptation element comprises at least two housing points of the horizontal support and/or the upper connection point, which gives a variable seat height.
Patent IL-162164-A0 (IL)
Title: Network load balancing
IPC: H04L12/56
Filed: 2004-05-24
Abstract: In a first exemplary media implementation, one or more processor-accessible media include processor-executable instructions that, when executed, direct a system to perform actions that include: accumulating host status information at multiple hosts; and sending the accumulated host status information from the multiple hosts. In a second exemplary media implementation, one or more processor-accessible media include processor-executable instructions that, when executed, direct a system to perform actions that include: receiving host status information from multiple hosts; and making load balancing decisions responsive to the received host status information. In a third exemplary media implementation, one or more processor-accessible media include processor-executable instructions that, when executed, direct a system to perform actions that include: determining health and load information on a per application basis; and selecting an application from among multiple applications responsive to the health and load information.
Patent IL-164222-A0 (IL)
Title: Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
IPC: A61K47/30
Filed: 2003-04-07
Abstract: The invention relates to liquid pharmaceutical formulations for oral administration with the modified release of active principle(s), excluding amoxicillin, said formulations consisting of suspensions of coated particles of active principles (microcapsules). According to the invention, the microcapsules constituting the disperse phase of the suspension are designed to allow the modified release of the active principle(s) according to a profile that does not change during the storage of the liquid suspension. To do this the inventors propose the selection of a specific coating composition for the microcapsules which consists of at least four components that allow these microcapsules to be stored in water without modifying their properties of modified release of the active principle, this liquid phase furthermore being saturated with active principle(s).